Evaluation of targeted influenza vaccination strategies via population modeling

PLoS ONE

Volumn 5, Issue 9, 2010, Pages 1-8

  Glasser, John ^a   Taneri, Denis ^a   Feng, Zhilan ^b   Chuang, Jen Hsiang ^c   Tüll, Peet ^d   Thompson, William ^a   McCauley, Mary Mason ^a   Alexander, James ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b PURDUE UNIVERSITY   (United States)

^c CENTER FOR DISEASE CONTROL   (Taiwan)

^d EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DRUG EFFICACY; GROUPS BY AGE; INFLUENZA VACCINATION; MORBIDITY; MORTALITY; PANDEMIC INFLUENZA; PNEUMONIA; POPULATION MODEL; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; CHILD; FEMALE; HEALTH CARE QUALITY; HEALTH SURVEY; HUMAN; IMMUNOLOGY; INFANT; INFLUENZA; MALE; MIDDLE AGED; PRESCHOOL CHILD; VACCINATION;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PROGRAM EVALUATION; VACCINATION; YOUNG ADULT;

EID: 77958585058     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0012777     Document Type: Article

References (46)

1. Advisory Committee on Immunization Practices (ACIP) (2009) Prevention and Control of Seasonal Influenza. MMWR Recommendations and Reports 2009 July 31;58(RR-8): 1-52.
2. Department of Health and Human Services (HHS) (2010) Pandemic Influenza Plan. Accessed March 23, 2010, at http://www.hhs.gov/pandemicflu/plan/.
3. Centers for Disease Control and Prevention (2008) Interim Within-Season Estimate of the Effectiveness of Trivalent Inactivated Influenza Vaccine - Marshfield, Wisconsin, 2007-08 Influenza Season. MMWR Weekly 2008 April 18; 57(15): 393-398.
4. Centers for Disease Control and Prevention (CDC). Seasonal Influenza Vaccine Supply and Distribution in the United States. Accessed March 23, 2010, at http://www.cdc.gov/flu/about/qa/vaxdistribution.htm.
5. Earn DJD, Dushoff J, Levin SA (2002) Ecology and evolution of the flu. Trends Ecol Evol 17: 334-340.
6. ACIP (2009) H1N1 Vaccination Recommendations. Accessed March 23, 2010 at http://www.cdc.gov/h1n1flu/vaccination/acip.htm.
7. Monto AS, Davenport FM, Napier JA, Francis T (1970) Modification of an outbreak of influenza in Tecumseh, Michigan by vaccinating schoolchildren. J Infect Dis 122: 16-25.
8. Reichert TA, Sugaya N, Fedson DS, Glezen WP, Simonsen L, et al. (2001) The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med 344: 889-896.
9. Longini IM, Halloran ME, Nizam A, Yang Y (2004) Containing pandemic influenza with antiviral agents. Am J Epidemiol 159: 623-633.
10. Chin TDY, Foley JF, Doto IL, Gravelle CR, Weston J (1960) Morbidity and mortality characteristics of Asian strain influenza. Public Health Rep 75: 149-158.
11. Del Valle SY, Hyman JM, Hethcote HW (2007) Mixing patterns between age groups in social networks. Soc Networks 29: 539-554.
12. CDC. National Vital Statistics System (2005) Public-Use Data Files and Documentation. Accessed March 23, 2010 at http://www.cdc.gov/nchs/data_access/ftp_data.htm.
13. Luk J, Gross P, Thompson WW (2001) Observations on mortality during the 1918 influenza pandemic. Clin Infect Dis 33: 1375-1378.
14. Bailey NTJ (1975) The Mathematical Theory of Infectious Diseases and Its Applications. London and High Wycombe, England: Charles Griffin and Company. 413 p.
15. Govaert TM, Thijs CT, Masurel N, Sprenger MJ, Dinant GJ, et al. (1994) The efficacy of influenza vaccination in elderly individuals. A randomized doubleblind placebo-controlled trial. JAMA 272: 1661-1665.
16. Koelle K, Cobey S, Grenfell B, Pascual M (2006) Epochal evolution shapes the phylodynamics of interpandemic influenza A (H3N2) in humans. Science 314: 1898-1903.
17. Izurieta HS, Thompson WW, Kramarz P, Shay DK, Davis RL, et al. (2000) Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med 342: 232-239.
18. Anderson RM, May RM (1991) Infectious Diseases of Humans: Dynamics and Control. Oxford, England: Oxford University Press. 757 p.
19. CDC, National Center for Health Statistics (2008) NCHS Health E-Stat: Vaccination coverage estimates from the National Health Interview Survey: United States, 2008. Accessed on March 25, 2010, at http://www.cdc.gov/nchs/data/hestat/vaccine_coverage.htm.
20. Renshaw E (1991) Modeling Biological Populations in Space and Time. Cambridge, England: Cambridge University Press. 403 p.
21. 0 in models for infectious diseases in heterogeneous populations. J Math Biol 28: 503-522.
22. Wallinga J, van Boven M, Lipsitch M (2010) Optimizing infectious disease interventions during an emerging epidemic. Proc Natl Acad Sci USA 107: 923-928.
23. Wallinga J, Teunis P, Kretzschmar M (2006) Using data on social contacts to estimate age-specific transmission parameters for respiratory-spread infectious agents. Am J Epidemiol 164: 936-944.
24. Hurford A, Cownden D, Day T (2010) Next-generation tools for evolutionary invasion analyses. J R Soc Interface 7: 561-571.
25. Mossong J, Hens N, Jit M, Beutels P, Auranen K, et al. (2008) Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med 5: 381-391.
26. Zagheni E, Billari FC, Manfredi P, Melegaro A, Mossong J, et al. (2008) Using time-use data to parameterize models for the spread of close-contact infectious diseases. Am J Epidemiol 168: 1082-1090.
27. Glezen WP (1996) Emerging infections: pandemic influenza. Epidemiol Rev 18: 64-76.
28. King JC, Jr., Cummings GE, Stoddard J, Readmond BX, Magder LS, et al. (2005) A pilot study of the effectiveness of a school-based influenza vaccination program. Pediatrics 116: e868-873.
29. King JC, Jr., Stoddard JJ, Gaglani MJ, Moore KA, Magderet L, et al. (2006) Effectiveness of school-based influenza vaccination. N Engl J Med 355: 2523-2532.
30. Loeb M, Russell ML, Moss L, Fonseca K, Fox J, et al. (2010) Effect of influenza vaccination of children on infection rates in Hutterite communities. JAMA 303: 943-950.
31. Dushoff J, Plotkin JB, Viboud C, Simonsen L, Miller M, et al. (2007) Vaccinating to protect a vulnerable subpopulation. PLoS Med 4: 921-927.
32. Bansal S, Pourbohloul B, Meyers LA (2006) A comparative analysis of influenza vaccination programs. PLoS Med 3: 1816-1825.
33. Medlock J, Galvani AP (2009) Optimizing influenza vaccine distribution. Science 325: 1705-1708.
34. Ferguson NM, Cummings DAT, Fraser C, Cajka JC, Cooley PC, et al. (2006) Strategies for mitigating an influenza pandemic. Nature 442: 448-452.
35. Germann TC, Kadau K, Longini IM, Macken CA (2006) Mitigation strategies for pandemic influenza in the United States. Proc Natl Acad Sci USA 103: 5935-5940.
36. Glass RJ, Glass LM, Beyeler WE, Min HJ (2006) Targeted social distancing design for pandemic influenza. Emerg Infect Dis 12: 1671-1681.
37. Haber MJ, Shay DK, Davis XM, Patel R, Jin X, et al. (2007) Effectiveness of interventions to reduce contact rates during a simulated influenza pandemic. Emerg Infect Dis 13: 581-589.
38. Longini IM, Nizam A, Xu S, Ungchusak K, Hanshaoworakulet W, et al. (2005) Containing pandemic influenza at the source. Science 309: 1083-1087.
39. May RM (2004) Uses and abuses of mathematics in biology. Science 303: 790-793.
40. Areno J, Brauer F, van den Driessche P, Watmough J, Wu J (2006) Simple models for containment of a pandemic. J R Soc Interface 3: 453-457.
41. Vynnycky E, Edmunds WJ (2008) Analyses of the 1957 (Asian) influenza pandemic in the United Kingdom and the impact of school closures. Epidemiol Infect 136: 166-179.
42. Nichol KL, Nordin JD, Nelson DB, Mullooly JP, Hak E (2007) Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med 357: 1373-1381.
43. Moscona A (2005) Neuraminidase inhibitors for influenza. N Engl J Med 353: 1363-1373.
44. Lipsitch M, Cohen T, Murray M, Levin BR (2007) Antiviral resistance and the control of pandemic influenza. PLoS Med 4: 111-121.
45. Nold A (1980) Heterogeneity in disease transmission modeling. Math Biosci 124: 59-82.
46. Jacquez JA, Simon CP, Koopman J, Sattenspiel L, Perry T (1988) Modeling and analyzing HIV transmission: the effect of contact patterns. Math Biosci 92: 119-199.